Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081
Condition:   Pulmonary Tuberculosis Interventions:   Drug: WX-081;   Drug: Bedaquiline;   Drug: Standard treatment;   Drug: Multi-drug background treatment (MBT) Sponsor:   Shanghai Jiatan Pharmatech Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2020 Category: Research Source Type: clinical trials

BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial
AbstractObjectivesThe BCG vaccine, widely used in Brazil in new-borns, induces adjuvant protection for several diseases, including childhood virus infections. BCG activates monocytes and innate memory NK cells which are crucial for the antiviral immune response. Therefore, strategies to prevent COVID-19 in health workers (HW) should be carried out to prevent them becoming unwell so that they can continue to work during the pandemic. The hypothesis is that BCG will improve the innate immune response and prevent symptomatic infection or COVID-19 severity.The primary objective is to verify the effectiveness and safety of the ...
Source: Trials - October 26, 2020 Category: Research Source Type: clinical trials

TB-LAM in the Diagnosis of TB
Conditions:   HIV Infections;   Tuberculosis;   Non-Tuberculous Mycobacterial Pneumonia Intervention:   Diagnostic Test: Alere TB-LAM Sponsor:   Shanghai Public Health Clinical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus
Conditions:   Diabetes Mellitus;   Tuberculosis Interventions:   Drug: Isoniazid and Rifapentine (INH-RPT);   Drug: Placebo Sponsors:   Dr. Nyanda Elias Ntinginya;   Stichting Katholieke Universiteit- Radboudumc (RUMC), Netherlands;   Otago University, New Zealand;   Makerere University;   St George's, University of London, United Kingdom;   Kilimanjaro Christian Medical University College (KCMUCo), Tanzania;   Uganda Martyrs Hospital Lubaga, Uganda;  ...
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

TB-LAM in the Diagnosis of TB
Conditions:   HIV Infections;   Tuberculosis;   Non-Tuberculous Mycobacterial Pneumonia Intervention:   Diagnostic Test: Alere TB-LAM Sponsor:   Shanghai Public Health Clinical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus
Conditions:   Diabetes Mellitus;   Tuberculosis Interventions:   Drug: Isoniazid and Rifapentine (INH-RPT);   Drug: Placebo Sponsors:   Dr. Nyanda Elias Ntinginya;   Stichting Katholieke Universiteit- Radboudumc (RUMC), Netherlands;   Otago University, New Zealand;   Makerere University;   St George's, University of London, United Kingdom;   Kilimanjaro Christian Medical University College (KCMUCo), Tanzania;   Uganda Martyrs Hospital Lubaga, Uganda;  ...
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

TB-LAM in the Diagnosis of TB
Conditions:   HIV Infections;   Tuberculosis;   Non-Tuberculous Mycobacterial Pneumonia Intervention:   Diagnostic Test: Alere TB-LAM Sponsor:   Shanghai Public Health Clinical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus
Conditions:   Diabetes Mellitus;   Tuberculosis Interventions:   Drug: Isoniazid and Rifapentine (INH-RPT);   Drug: Placebo Sponsors:   Dr. Nyanda Elias Ntinginya;   Stichting Katholieke Universiteit- Radboudumc (RUMC), Netherlands;   Otago University, New Zealand;   Makerere University;   St George's, University of London, United Kingdom;   Kilimanjaro Christian Medical University College (KCMUCo), Tanzania;   Uganda Martyrs Hospital Lubaga, Uganda;  ...
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

TB-LAM in the Diagnosis of TB
Conditions:   HIV Infections;   Tuberculosis;   Non-Tuberculous Mycobacterial Pneumonia Intervention:   Diagnostic Test: Alere TB-LAM Sponsor:   Shanghai Public Health Clinical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus
Conditions:   Diabetes Mellitus;   Tuberculosis Interventions:   Drug: Isoniazid and Rifapentine (INH-RPT);   Drug: Placebo Sponsors:   Dr. Nyanda Elias Ntinginya;   Stichting Katholieke Universiteit- Radboudumc (RUMC), Netherlands;   Otago University, New Zealand;   Makerere University;   St George's, University of London, United Kingdom;   Kilimanjaro Christian Medical University College (KCMUCo), Tanzania;   Uganda Martyrs Hospital Lubaga, Uganda;  ...
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

TB-LAM in the Diagnosis of TB
Conditions:   HIV Infections;   Tuberculosis;   Non-Tuberculous Mycobacterial Pneumonia Intervention:   Diagnostic Test: Alere TB-LAM Sponsor:   Shanghai Public Health Clinical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus
Conditions:   Diabetes Mellitus;   Tuberculosis Interventions:   Drug: Isoniazid and Rifapentine (INH-RPT);   Drug: Placebo Sponsors:   Dr. Nyanda Elias Ntinginya;   Stichting Katholieke Universiteit- Radboudumc (RUMC), Netherlands;   Otago University, New Zealand;   Makerere University;   St George's, University of London, United Kingdom;   Kilimanjaro Christian Medical University College (KCMUCo), Tanzania;   Uganda Martyrs Hospital Lubaga, Uganda;  ...
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

TB-LAM in the Diagnosis of TB
Conditions:   HIV Infections;   Tuberculosis;   Non-Tuberculous Mycobacterial Pneumonia Intervention:   Diagnostic Test: Alere TB-LAM Sponsor:   Shanghai Public Health Clinical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus
Conditions:   Diabetes Mellitus;   Tuberculosis Interventions:   Drug: Isoniazid and Rifapentine (INH-RPT);   Drug: Placebo Sponsors:   Dr. Nyanda Elias Ntinginya;   Stichting Katholieke Universiteit- Radboudumc (RUMC), Netherlands;   Otago University, New Zealand;   Makerere University;   St George's, University of London, United Kingdom;   Kilimanjaro Christian Medical University College (KCMUCo), Tanzania;   Uganda Martyrs Hospital Lubaga, Uganda;  ...
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

TB-LAM in the Diagnosis of TB
Conditions:   HIV Infections;   Tuberculosis;   Non-Tuberculous Mycobacterial Pneumonia Intervention:   Diagnostic Test: Alere TB-LAM Sponsor:   Shanghai Public Health Clinical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus
Conditions:   Diabetes Mellitus;   Tuberculosis Interventions:   Drug: Isoniazid and Rifapentine (INH-RPT);   Drug: Placebo Sponsors:   Dr. Nyanda Elias Ntinginya;   Stichting Katholieke Universiteit- Radboudumc (RUMC), Netherlands;   Otago University, New Zealand;   Makerere University;   St George's, University of London, United Kingdom;   Kilimanjaro Christian Medical University College (KCMUCo), Tanzania;   Uganda Martyrs Hospital Lubaga, Uganda;  ...
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

TB-LAM in the Diagnosis of TB
Conditions:   HIV Infections;   Tuberculosis;   Non-Tuberculous Mycobacterial Pneumonia Intervention:   Diagnostic Test: Alere TB-LAM Sponsor:   Shanghai Public Health Clinical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus
Conditions:   Diabetes Mellitus;   Tuberculosis Interventions:   Drug: Isoniazid and Rifapentine (INH-RPT);   Drug: Placebo Sponsors:   Dr. Nyanda Elias Ntinginya;   Stichting Katholieke Universiteit- Radboudumc (RUMC), Netherlands;   Otago University, New Zealand;   Makerere University;   St George's, University of London, United Kingdom;   Kilimanjaro Christian Medical University College (KCMUCo), Tanzania;   Uganda Martyrs Hospital Lubaga, Uganda;  ...
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

TB-LAM in the Diagnosis of TB
Conditions:   HIV Infections;   Tuberculosis;   Non-Tuberculous Mycobacterial Pneumonia Intervention:   Diagnostic Test: Alere TB-LAM Sponsor:   Shanghai Public Health Clinical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials

The Role of Vitamin D, A, and Beta Carotene in Tuberculosis Patients With Vitamin D Receptor Gene Polymorphism
Condition:   Tuberculosis Interventions:   Dietary Supplement: vitamin D 1000 IU and A 6000 IU supplementation and nutritional counseling;   Other: nutritional Counseling Sponsor:   Universitas Sumatera Utara Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2020 Category: Research Source Type: clinical trials

Phase I Clinical Protocol of BCG-PPD in Healthy People
Condition:   Tuberculosis Intervention:   Drug: BCG-PPD Sponsors:   Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.;   Sichuan Center for Disease Control and Prevention;   Neijiang Center for Disease Control and Prevention;   Beijing Kangterike Statistical Technology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2020 Category: Research Source Type: clinical trials

The Role of Vitamin D, A, and Beta Carotene in Tuberculosis Patients With Vitamin D Receptor Gene Polymorphism
Condition:   Tuberculosis Interventions:   Dietary Supplement: vitamin D 1000 IU and A 6000 IU supplementation and nutritional counseling;   Other: nutritional Counseling Sponsor:   Universitas Sumatera Utara Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2020 Category: Research Source Type: clinical trials

Phase I Clinical Protocol of BCG-PPD in Healthy People
Condition:   Tuberculosis Intervention:   Drug: BCG-PPD Sponsors:   Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.;   Sichuan Center for Disease Control and Prevention;   Neijiang Center for Disease Control and Prevention;   Beijing Kangterike Statistical Technology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2020 Category: Research Source Type: clinical trials

The Role of Vitamin D, A, and Beta Carotene in Tuberculosis Patients With Vitamin D Receptor Gene Polymorphism
Condition:   Tuberculosis Interventions:   Dietary Supplement: vitamin D 1000 IU and A 6000 IU supplementation and nutritional counseling;   Other: nutritional Counseling Sponsor:   Universitas Sumatera Utara Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2020 Category: Research Source Type: clinical trials

Phase I Clinical Protocol of BCG-PPD in Healthy People
Condition:   Tuberculosis Intervention:   Drug: BCG-PPD Sponsors:   Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.;   Sichuan Center for Disease Control and Prevention;   Neijiang Center for Disease Control and Prevention;   Beijing Kangterike Statistical Technology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2020 Category: Research Source Type: clinical trials

The Role of Vitamin D, A, and Beta Carotene in Tuberculosis Patients With Vitamin D Receptor Gene Polymorphism
Condition:   Tuberculosis Interventions:   Dietary Supplement: vitamin D 1000 IU and A 6000 IU supplementation and nutritional counseling;   Other: nutritional Counseling Sponsor:   Universitas Sumatera Utara Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2020 Category: Research Source Type: clinical trials

Phase I Clinical Protocol of BCG-PPD in Healthy People
Condition:   Tuberculosis Intervention:   Drug: BCG-PPD Sponsors:   Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.;   Sichuan Center for Disease Control and Prevention;   Neijiang Center for Disease Control and Prevention;   Beijing Kangterike Statistical Technology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2020 Category: Research Source Type: clinical trials

The Role of Vitamin D, A, and Beta Carotene in Tuberculosis Patients With Vitamin D Receptor Gene Polymorphism
Condition:   Tuberculosis Interventions:   Dietary Supplement: vitamin D 1000 IU and A 6000 IU supplementation and nutritional counseling;   Other: nutritional Counseling Sponsor:   Universitas Sumatera Utara Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2020 Category: Research Source Type: clinical trials

Phase I Clinical Protocol of BCG-PPD in Healthy People
Condition:   Tuberculosis Intervention:   Drug: BCG-PPD Sponsors:   Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.;   Sichuan Center for Disease Control and Prevention;   Neijiang Center for Disease Control and Prevention;   Beijing Kangterike Statistical Technology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2020 Category: Research Source Type: clinical trials

The Role of Vitamin D, A, and Beta Carotene in Tuberculosis Patients With Vitamin D Receptor Gene Polymorphism
Condition:   Tuberculosis Interventions:   Dietary Supplement: vitamin D 1000 IU and A 6000 IU supplementation and nutritional counseling;   Other: nutritional Counseling Sponsor:   Universitas Sumatera Utara Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2020 Category: Research Source Type: clinical trials

Phase I Clinical Protocol of BCG-PPD in Healthy People
Condition:   Tuberculosis Intervention:   Drug: BCG-PPD Sponsors:   Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.;   Sichuan Center for Disease Control and Prevention;   Neijiang Center for Disease Control and Prevention;   Beijing Kangterike Statistical Technology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2020 Category: Research Source Type: clinical trials

The Role of Vitamin D, A, and Beta Carotene in Tuberculosis Patients With Vitamin D Receptor Gene Polymorphism
Condition:   Tuberculosis Interventions:   Dietary Supplement: vitamin D 1000 IU and A 6000 IU supplementation and nutritional counseling;   Other: nutritional Counseling Sponsor:   Universitas Sumatera Utara Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2020 Category: Research Source Type: clinical trials